Indication
Ventilator-associated pneumonia due to Acinetobacter
Ventilator-associated pneumonia due to *Acinetobacter* is a severe hospital-acquired lower respiratory tract infection arising in critically ill patients undergoing invasive mechanical ventilation for 48 hours or more. Read more about Ventilator-associated pneumonia due to Acinetobacter
3 drugs 1 manufacturers
Drugs that treat it
Common Ventilator-associated pneumonia due to Acinetobacter therapies.
DURLOBACTAM (XACDURO) (durlobactam sodium)
SULBACTAM (XACDURO) (sulbactam sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVentilator-associated pneumonia due to *Acinetobacter* is a severe hospital-acquired lower respiratory tract infection arising in critically ill patients undergoing invasive mechanical ventilation for 48 hours or more.
It primarily affects the pulmonary parenchyma of intensive care unit populations following bacterial colonization of the airways and microaspiration around the endotracheal tube cuff.
The infection is characterized by new or progressive pulmonary infiltrates on chest imaging, fever, purulent endotracheal secretions, leukocytosis, and worsening gas exchange, with microbiological confirmation of *Acinetobacter* species (commonly the *Acinetobacter baumannii-calcoaceticus* complex) from lower respiratory tract cultures.
It frequently involves multidrug-resistant strains, presenting a high risk of treatment failure, septic shock, and in-hospital mortality.
- nih.gov
Ventilator-associated pneumonia due to *Acinetobacter* is a severe hospital-acquired lower respiratory tract infection arising in critically ill patients undergoing invasive mechanical ventilation for 48 hours or more It primarily affects the pulmonary parenchyma of intensive care unit populations following bacterial colonization of the airways and microaspiration around the endotracheal tube cuff The infection is characterized by new or progressive pulmonary infiltrates on chest imaging, fever,...
- nih.gov
Ventilator-associated pneumonia due to *Acinetobacter* is a severe hospital-acquired lower respiratory tract infection arising in critically ill patients undergoing invasive mechanical ventilation for 48 hours or more The infection is characterized by new or progressive pulmonary infiltrates on chest imaging, fever, purulent endotracheal secretions, leukocytosis, and worsening gas exchange, with microbiological confirmation of *Acinetobacter* species (commonly the *Acinetobacter baumannii-calcoa...
- youtube.com
It primarily affects the pulmonary parenchyma of intensive care unit populations following bacterial colonization of the airways and microaspiration around the endotracheal tube cuff
- clinicallab.com
The infection is characterized by new or progressive pulmonary infiltrates on chest imaging, fever, purulent endotracheal secretions, leukocytosis, and worsening gas exchange, with microbiological confirmation of *Acinetobacter* species (commonly the *Acinetobacter baumannii-calcoaceticus* complex) from lower respiratory tract cultures
- nih.gov
It frequently involves multidrug-resistant strains, presenting a high risk of treatment failure, septic shock, and in-hospital mortality
- nih.gov
It frequently involves multidrug-resistant strains, presenting a high risk of treatment failure, septic shock, and in-hospital mortality
- nih.gov
It frequently involves multidrug-resistant strains, presenting a high risk of treatment failure, septic shock, and in-hospital mortality
Personalize your experience
Follow Ventilator-associated pneumonia due to Acinetobacter and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.